Pancreatic Cancer Precision Medicine Global Market Report 2025
상품코드:1760668
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
췌장암 정밀 의료 시장 규모는 향후 몇 년간 급속한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 개인 맞춤형 종양학 연구에 대한 투자 증가, 바이오마커 기반 진단 테스트의 이용 가능성 확대, 표적 치료의 채택 증가, 정밀 치료를 위한 임상 시험의 파이프라인 확대, 개인 맞춤형 의료에 대한 지원 규제 이니셔티브, 생명공학 기업과 연구 기관 간의 협력 확대 등 여러 요인에 기인할 수 있습니다. 예측 기간 동안의 주요 동향으로는 액체 생검 기술의 발전, 개인 맞춤형 면역 요법의 개발, AI 기반 예측 분석의 채택, 새로운 바이오마커의 발견, 보다 상세한 종양 프로파일링을 위한 멀티 오믹스 접근법의 통합, 표적 조합 요법의 부상이 있습니다.
췌장암의 발병률이 증가함에 따라 췌장암 정밀 의료 시장의 확장이 촉진될 것으로 예상됩니다. 소화 및 혈당 조절에 중요한 기관인 췌장에서 시작되는 췌장암은 인구 고령화, 비만, 당뇨병, 흡연 등 위험 요인의 증가로 인해 발병률이 증가하고 있습니다. 췌장암에 대한 정밀 의학은 유전 및 분자 데이터를 기반으로 개인 맞춤형 치료 계획을 제공하여 치료 결과를 개선합니다. 이 접근 방식은 치료 효과를 높이고 부작용을 최소화하여 보다 효율적인 암 관리에 필수적인 도구입니다. 예를 들어, 2025년 2월 호주 암 연구소(Cancer Australia)는 2024년 췌장암 신규 환자가 4,641명으로, 이 중 남성 2,414명, 여성 2,227명으로 2023년 3,968건 대비 증가했다고 보고했습니다. 이처럼 췌장암 발생률의 증가는 해당 질환의 정밀 의료 시장 성장에 기여하고 있습니다.
췌장암 정밀 의료 시장 선도 기업들은 정밀 의료 도구와 같은 고급 기술 개발에 집중하고 있습니다. 이는 조기 진단 개선, 정확한 종양 프로파일링, 환자 맞춤형 치료 전략 최적화를 통해 환자 예후를 향상시키는 것을 목표로 합니다. 정밀 의료 도구는 개인의 고유한 생물학적 특성에 기반해 질병의 진단과 치료를 지원하는 전문 장치입니다. 예를 들어, 2024년 1월 미국 기반 의료 기관인 세다스-시나이(Cedars-Sinai)는 분자 쌍 정밀 종양학 플랫폼을 출시했습니다. 이 도구는 주요 바이오마커를 식별해 췌장암 생존율을 더 정확히 예측하는 것을 목표로 합니다. 이 플랫폼은 74명의 췌관 선암 환자에서 채취한 혈액 및 조직 샘플을 활용해 정밀 암 치료에 대한 더 정확하고 접근 가능한 접근 방식을 제공함으로써, 자원 부족 지역에서도 치료 결정에 대한 지침을 제공하는 데 강력한 잠재력을 보유하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 췌장암 정밀 의료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 췌장암 정밀 의료 시장 : 성장률 분석
세계의 췌장암 정밀 의료 시장 실적 : 규모와 성장(2019-2024년)
세계의 췌장암 정밀 의료 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 췌장암 정밀 의료 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 췌장암 정밀 의료 시장 : 치료 접근법별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
표적 치료
면역 요법
화학 요법과 정밀 요법의 병용
기타 치료방법
세계의 췌장암 정밀 의료 시장 : 진단 기술별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
유전체 검사
분자 진단
액체 생검
바이오마커 기반 동반진단
기타 진단 기술
세계의 췌장암 정밀 의료 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
전문 클리닉
학술연구기관
진단 센터
세계의 췌장암 정밀 의료 시장, 표적 치료 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
키나아제 억제제
PARP 억제제
기타 분자 표적 약물
세계의 췌장암 정밀 의료 시장, 면역 요법 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
면역 체크포인트 억제제
암 백신
적응 세포 요법
기타 면역요법 접근
세계의 췌장암 정밀 의료 시장, 화학 요법과 정밀 요법의 병용 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
젬시타빈 기반 병용
플루오로우라실 기반 병용
나부파클리탁셀 기반 병용
기타 화학 요법 병용
세계의 췌장암 정밀 의료 시장, 기타 치료 방법 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
RNA 기반 치료법
후성적 모듈레이터
항체 약물 복합체(ADC)
제7장 지역별, 국가별 분석
세계의 췌장암 정밀 의료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 췌장암 정밀 의료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
췌장암 정밀 의료 시장 : 경쟁 구도
췌장암 정밀 의료 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Bristol-Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Thermo Fisher Scientific Inc.
AstraZeneca Plc
Novartis AG
Eli Lilly and Company
Amgen Inc
Teva Pharmaceutical Industries Ltd
Genentech Inc.
Illumina Inc.
Ipsen Pharma
Guardant Health
FOUNDATION MEDICINE INC.
Oncolytics Biotech Inc.
Celgene Corporation
Erytech Pharma
PharmaCyte Biotech Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
췌장암 정밀 의료 시장(2029년) : 새로운 기회를 제공하는 국가
췌장암 Precision Medicine Market 2029 : 새로운 기회를 제공하는 부문
췌장암 정밀 의료 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Pancreatic cancer precision medicine is a specialized treatment approach that tailors care to individual pancreatic cancer patients. It uses the patient's genetic and molecular information, both from their body and their cancer, to develop a personalized treatment plan. This approach improves patient outcomes by customizing treatment, reducing unnecessary interventions, and increasing the chances of successful outcomes.
The primary therapeutic strategies in pancreatic cancer precision medicine include targeted therapy, immunotherapy, chemotherapy-precision combinations, and others. Targeted therapy involves drugs specifically designed to act on genetic mutations, proteins, or other molecules that contribute to the growth and spread of cancer cells. A variety of diagnostic technologies support these treatments, such as genomic testing, molecular diagnostics, liquid biopsy, and biomarker-based companion diagnostics. These technologies and therapies are applied in settings such as hospitals, specialty clinics, academic and research institutes, and diagnostic centers.
The pancreatic cancer precision medicine market research report is one of a series of new reports from The Business Research Company that provides pancreatic cancer precision medicine market statistics, including the pancreatic cancer precision medicine industry global market size, regional shares, competitors with the pancreatic cancer precision medicine market share, detailed pancreatic cancer precision medicine market segments, market trends, and opportunities, and any further data you may need to thrive in the pancreatic cancer precision medicine industry. This pancreatic cancer precision medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The pancreatic cancer precision medicine market size has grown rapidly in recent years. It will grow from $0.49 billion in 2024 to $0.58 billion in 2025 at a compound annual growth rate (CAGR) of 17.3%. The growth during the historic period can be attributed to several factors, including the rising incidence of pancreatic cancer, advancements in the understanding of tumor heterogeneity, increased investment in oncology research, greater availability of biomarker-driven therapies, improved diagnostic tools for early detection, and a growing adoption of personalized treatment approaches.
The pancreatic cancer precision medicine market size is expected to see rapid growth in the next few years. It will grow to $1.08 billion in 2029 at a compound annual growth rate (CAGR) of 17.9%. The growth during the forecast period can be attributed to several factors, including increasing investments in personalized oncology research, greater availability of biomarker-based diagnostic tests, rising adoption of targeted therapies, a growing pipeline of clinical trials for precision treatments, supportive regulatory initiatives for personalized medicine, and expanding collaborations between biotech companies and research institutions. Key trends in the forecast period include advancements in liquid biopsy technologies, the development of personalized immunotherapies, the adoption of AI-driven predictive analytics, the emergence of new biomarker discoveries, the integration of multi-omics approaches for more detailed tumor profiling, and the rise of targeted combination therapies.
The growing incidence of pancreatic cancer is anticipated to drive the expansion of the pancreatic cancer precision medicine market. Pancreatic cancer, which begins in the pancreas-an organ crucial for digestion and blood sugar regulation-has seen a rise in cases due to factors such as an aging population and the increasing prevalence of risk factors such as obesity, diabetes, and smoking. Precision medicine for pancreatic cancer improves treatment outcomes by providing personalized treatment plans based on genetic and molecular data. This approach enhances treatment effectiveness and minimizes side effects, making it an essential tool for more efficient cancer management. For example, in February 2025, Cancer Australia reported that there were 4,641 new cases of pancreatic cancer in 2024, with 2,414 in males and 2,227 in females, marking an increase from 3,968 cases in 2023. As such, the growing incidence of pancreatic cancer is contributing to the growth of the precision medicine market for this disease.
Leading companies in the pancreatic cancer precision medicine market are increasingly focusing on developing advanced technologies, such as precision medical tools, to enhance early detection, enable accurate tumor profiling, and optimize personalized treatment strategies for better patient outcomes. Precision medical tools are specialized devices that assist in diagnosing and treating diseases based on an individual's unique biology. For instance, in January 2024, Cedars-Sinai, a U.S.-based healthcare organization, launched the molecular twin precision oncology platform. This tool aims to more accurately predict pancreatic cancer survival by identifying key biomarkers. The platform has strong potential for guiding treatment decisions, even in areas with limited resources, by using blood and tissue samples from 74 pancreatic ductal adenocarcinoma patients to provide a more precise and accessible approach to precision oncology.
In September 2022, Oncodesign Precision Medicine (OPM), a biotechnology firm based in France, entered into a collaboration with Servier Laboratories to identify and validate new therapeutic targets in pancreatic ductal adenocarcinoma (PDAC). This collaboration seeks to accelerate the development of precision medicine for cancer treatment by combining OPM's expertise in biomarkers and therapeutic solutions with Servier's oncology research and drug development capabilities. Servier Laboratories is a French pharmaceutical company specializing in treatments for oncology and immuno-inflammatory diseases.
Major players in the pancreatic cancer precision medicine market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Novartis AG, Eli Lilly and Company, Amgen Inc, Teva Pharmaceutical Industries Ltd, Genentech Inc., Illumina Inc., Ipsen Pharma, Guardant Health, FOUNDATION MEDICINE INC., Oncolytics Biotech Inc., Celgene Corporation, Erytech Pharma, PharmaCyte Biotech Inc.
North America was the largest region in the pancreatic cancer precision medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pancreatic cancer precision medicine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the pancreatic cancer precision medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pancreatic cancer precision medicine market includes revenues earned by entities by providing services such as personalized treatment planning, tumour molecular profiling, precision imaging and diagnostics, and targeted therapeutics. The market value includes the value of related goods sold by the service provider or included within the service offering. The pancreatic cancer precision medicine market consists of sales of genetic and biomarker testing kits, immunotherapy drugs, and personalized cancer vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pancreatic Cancer Precision Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pancreatic cancer precision medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for pancreatic cancer precision medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pancreatic cancer precision medicine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Therapeutic Approach: Targeted Therapy; Immunotherapy; Chemotherapy-Precision Combinations; Other Therapeutic Approache
2) By Diagnostic Technology: Genomic Testing; Molecular Diagnostics; Liquid Biopsy; Biomarker-Based Companion Diagnostics; Other Diagnostic Technologies
3) By Application: Hospitals; Specialty Clinics; Academic And Research Institutes; Diagnostic Centers
Subsegments:
1) By Targeted Therapy: Kinase Inhibitors; PARP Inhibitors; Other Molecular Targeted Agents
2) By Immunotherapy: Immune Checkpoint Inhibitors; Cancer Vaccines; Adoptive Cell Therapy; Other Immunotherapy Approaches
3) By Chemotherapy-Precision Combinations: Gemcitabine-Based Combinations; Fluorouracil-Based Combinations; Nab-Paclitaxel-Based Combinations; Other Chemotherapy Combinations
4) By Other Therapeutic Approaches: RNA-Based Therapies; Epigenetic Modulators; Antibody-Drug Conjugates (ADCs); Other Innovative Therapies
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Bristol-Myers Squibb Company
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Pancreatic Cancer Precision Medicine Market Characteristics
3. Pancreatic Cancer Precision Medicine Market Trends And Strategies
4. Pancreatic Cancer Precision Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Pancreatic Cancer Precision Medicine Growth Analysis And Strategic Analysis Framework
5.1. Global Pancreatic Cancer Precision Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Pancreatic Cancer Precision Medicine Market Growth Rate Analysis
5.4. Global Pancreatic Cancer Precision Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Pancreatic Cancer Precision Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Pancreatic Cancer Precision Medicine Total Addressable Market (TAM)
6. Pancreatic Cancer Precision Medicine Market Segmentation
6.1. Global Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Targeted Therapy
Immunotherapy
Chemotherapy-Precision Combinations
Other Therapeutic Approaches
6.2. Global Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genomic Testing
Molecular Diagnostics
Liquid Biopsy
Biomarker-Based Companion Diagnostics
Other Diagnostic Technologies
6.3. Global Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Academic And Research Institutes
Diagnostic Centers
6.4. Global Pancreatic Cancer Precision Medicine Market, Sub-Segmentation Of Targeted Therapy By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Kinase Inhibitors
PARP Inhibitors
Other Molecular Targeted Agents
6.5. Global Pancreatic Cancer Precision Medicine Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immune Checkpoint Inhibitors
Cancer Vaccines
Adoptive Cell Therapy
Other Immunotherapy Approaches
6.6. Global Pancreatic Cancer Precision Medicine Market, Sub-Segmentation Of Chemotherapy-Precision Combinations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gemcitabine-Based Combinations
Fluorouracil-Based Combinations
Nab-Paclitaxel-Based Combinations
Other Chemotherapy Combinations
6.7. Global Pancreatic Cancer Precision Medicine Market, Sub-Segmentation Of Other Therapeutic Approaches, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
RNA-Based Therapies
Epigenetic Modulators
Antibody-Drug Conjugates (ADCs)
7. Pancreatic Cancer Precision Medicine Market Regional And Country Analysis
7.1. Global Pancreatic Cancer Precision Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Pancreatic Cancer Precision Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Pancreatic Cancer Precision Medicine Market
8.1. Asia-Pacific Pancreatic Cancer Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Pancreatic Cancer Precision Medicine Market
9.1. China Pancreatic Cancer Precision Medicine Market Overview
9.2. China Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Pancreatic Cancer Precision Medicine Market
10.1. India Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Pancreatic Cancer Precision Medicine Market
11.1. Japan Pancreatic Cancer Precision Medicine Market Overview
11.2. Japan Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Pancreatic Cancer Precision Medicine Market
12.1. Australia Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Pancreatic Cancer Precision Medicine Market
13.1. Indonesia Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Pancreatic Cancer Precision Medicine Market
14.1. South Korea Pancreatic Cancer Precision Medicine Market Overview
14.2. South Korea Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Pancreatic Cancer Precision Medicine Market
15.1. Western Europe Pancreatic Cancer Precision Medicine Market Overview
15.2. Western Europe Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Pancreatic Cancer Precision Medicine Market
16.1. UK Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Pancreatic Cancer Precision Medicine Market
17.1. Germany Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Pancreatic Cancer Precision Medicine Market
18.1. France Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Pancreatic Cancer Precision Medicine Market
19.1. Italy Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Pancreatic Cancer Precision Medicine Market
20.1. Spain Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Pancreatic Cancer Precision Medicine Market
21.1. Eastern Europe Pancreatic Cancer Precision Medicine Market Overview
21.2. Eastern Europe Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Pancreatic Cancer Precision Medicine Market
22.1. Russia Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Pancreatic Cancer Precision Medicine Market
23.1. North America Pancreatic Cancer Precision Medicine Market Overview
23.2. North America Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Pancreatic Cancer Precision Medicine Market
24.1. USA Pancreatic Cancer Precision Medicine Market Overview
24.2. USA Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Pancreatic Cancer Precision Medicine Market
25.1. Canada Pancreatic Cancer Precision Medicine Market Overview
25.2. Canada Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Pancreatic Cancer Precision Medicine Market
26.1. South America Pancreatic Cancer Precision Medicine Market Overview
26.2. South America Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Pancreatic Cancer Precision Medicine Market
27.1. Brazil Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Pancreatic Cancer Precision Medicine Market
28.1. Middle East Pancreatic Cancer Precision Medicine Market Overview
28.2. Middle East Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Pancreatic Cancer Precision Medicine Market
29.1. Africa Pancreatic Cancer Precision Medicine Market Overview
29.2. Africa Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Pancreatic Cancer Precision Medicine Market Competitive Landscape And Company Profiles
30.1. Pancreatic Cancer Precision Medicine Market Competitive Landscape
30.2. Pancreatic Cancer Precision Medicine Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
31. Pancreatic Cancer Precision Medicine Market Other Major And Innovative Companies
31.1. Thermo Fisher Scientific Inc.
31.2. AstraZeneca Plc
31.3. Novartis AG
31.4. Eli Lilly and Company
31.5. Amgen Inc
31.6. Teva Pharmaceutical Industries Ltd
31.7. Genentech Inc.
31.8. Illumina Inc.
31.9. Ipsen Pharma
31.10. Guardant Health
31.11. FOUNDATION MEDICINE INC.
31.12. Oncolytics Biotech Inc.
31.13. Celgene Corporation
31.14. Erytech Pharma
31.15. PharmaCyte Biotech Inc.
32. Global Pancreatic Cancer Precision Medicine Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Pancreatic Cancer Precision Medicine Market
34. Recent Developments In The Pancreatic Cancer Precision Medicine Market
35. Pancreatic Cancer Precision Medicine Market High Potential Countries, Segments and Strategies
35.1 Pancreatic Cancer Precision Medicine Market In 2029 - Countries Offering Most New Opportunities
35.2 Pancreatic Cancer Precision Medicine Market In 2029 - Segments Offering Most New Opportunities
35.3 Pancreatic Cancer Precision Medicine Market In 2029 - Growth Strategies
